|
1.
|
Go AS, Chertow GM, Fan D, McCulloch CE and
Hsu CY: Chronic kidney disease and the risks of death,
cardiovascular events, and hospitalization. N Engl J Med.
351:1296–1305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ruilope LM, Salvetti A, Jamerson K, et al:
Renal function and intensive lowering of blood pressure in
hypertensive participants of the hypertension optimal treatment
(HOT) study. J Am Soc Nephrol. 12:218–225. 2001.PubMed/NCBI
|
|
3.
|
National Kidney Foundation: K/DOQI
clinical practice guidelines for chronic kidney disease:
evaluation, classification, and stratification. Am J Kidney Dis.
39(Suppl 1): 1–266. 2002.PubMed/NCBI
|
|
4.
|
Yamagata K, Ishida K, Sairenchi T, et al:
Risk factors for chronic kidney disease in a community-based
population: a 10-year follow-up study. Kidney Int. 71:159–166.
2007.PubMed/NCBI
|
|
5.
|
Norris KC, Tareen N, Martins D and Vaziri
ND: Implications of ethnicity for the treatment of hypertensive
kidney disease, with an emphasis on African Americans. Nat Clin
Pract Nephrol. 4:538–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Sarafidis PA, Li S, Chen SC, et al:
Hypertension awareness, treatment, and control in chronic kidney
disease. Am J Med. 121:332–340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
James MT, Hemmelgarn BR and Tonelli M:
Early recognition and prevention of chronic kidney disease. Lancet.
375:1296–1309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Yoshida T, Kato K, Yokoi K, et al:
Association of candidate gene polymorphisms with chronic kidney
disease in Japanese individuals with hypertension. Hypertens Res.
32:411–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kottgen A, Kao WH, Hwang SJ, et al:
Genome-wide association study for renal traits in the Framingham
Heart and Atherosclerosis Risk in Communities Studies. BMC Med
Genet. 9:492008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chambers JC, Zhang W, Lord GM, et al:
Genetic loci influencing kidney function and chronic kidney
disease. Nat Genet. 42:373–375. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Köttgen A, Pattaro C, Böger CA, et al: New
loci associated with kidney function and chronic kidney disease.
Nat Genet. 42:376–384. 2010.
|
|
12.
|
Köttgen A, Glazer NL, Dehghan A, et al:
Multiple loci associated with indices of renal function and chronic
kidney disease. Nat Genet. 41:712–717. 2009.PubMed/NCBI
|
|
13.
|
Kao WH, Klag MJ, Meoni LA, et al Family
Investigation of Nephropathy and Diabetes Research Group: MYH9 is
associated with nondiabetic end-stage renal disease in African
Americans. Nat Genet. 40:1185–1192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gharavi AG, Yan Y, Scolari F, et al: IgA
nephropathy, the most common cause of glomerulonephritis, is linked
to 6q22–23. Nat Genet. 26:354–357. 2000.PubMed/NCBI
|
|
15.
|
Hanson RL, Craig DW, Millis MP, et al:
Identification of PVT1 as a candidate gene for end-stage renal
disease in type 2 diabetes using a pooling-based genome-wide single
nucleotide polymorphism association study. Diabetes. 56:975–983.
2007. View Article : Google Scholar
|
|
16.
|
Yamada Y, Nishida T, Ichihara S, et al:
Association of a polymorphism of BTN2A1 with myocardial infarction
in East Asian populations. Atherosclerosis. (In Press).
|
|
17.
|
Yoshida T, Kato K, Fujimaki T, et al:
Association of a polymorphism of the apolipoprotein E gene with
chronic kidney disease in Japanese individuals with metabolic
syndrome. Genomics. 93:221–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yoshida T, Kato K, Yokoi K, et al:
Association of genetic variants with chronic kidney disease in
Japanese individuals with type 2 diabetes mellitus. Int J Mol Med.
23:529–537. 2009.PubMed/NCBI
|
|
19.
|
Yoshida T, Kato K, Yokoi K, et al:
Association of genetic variants with chronic kidney disease in
individuals with different lipid profiles. Int J Mol Med.
24:233–246. 2009.PubMed/NCBI
|
|
20.
|
Matsuo S, Imai E, Horio M, et al: Revised
equations for estimated GFR from serum creatinine in Japan. Am J
Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ogg SL, Weldon AK, Dobbie L, Smith AJ and
Mather IH: Expression of butyrophilin (Btn1a1) in lactating mammary
gland is essential for the regulated secretion of milk-lipid
droplets. Proc Natl Acad Sci USA. 101:10084–10089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Arnett HA, Escobar SS and Viney JL:
Regulation of costimulation in the era of butyrophilins. Cytokine.
46:370–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Valentonyte R, Hampe J, Huse K, et al:
Sarcoidosis is associated with a truncating splice site mutation in
BTNL2. Nat Genet. 37:357–364. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Mochida A, Kinouchi Y, Negoro K, et al:
Butyrophilin-like 2 gene is associated with ulcerative colitis in
the Japanese under strong linkage disequilibrium with
HLA-DRB1*1502. Tissue Antigens. 70:128–135. 2007.PubMed/NCBI
|
|
25.
|
Orozco G, Eerligh P, Sánchez E, et al:
Analysis of a functional BTNL2 polymorphism in type 1 diabetes,
rheumatoid arthritis, and systemic lupus erythematosus. Hum
Immunol. 66:1235–1241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Traherne JA, Barcellos LF, Sawcer SJ, et
al: Association of the truncating splice site mutation in BTNL2
with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet.
15:155–161. 2006.PubMed/NCBI
|
|
27.
|
Keane WF, Kasiske BL, O'Donnell MP and Kim
Y: Hypertension, hyperlipidemia, and renal damage. Am J Kidney Dis.
21(Suppl 2): 43–50. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Fassett RG, D'Intini V, Healy H, et al:
Assessment of arterial stiffness, oxidative stress and inflammation
in acute kidney injury. BMC Nephrol. 10:152009. View Article : Google Scholar : PubMed/NCBI
|
